简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2022-03-16 11:33 Zayed Sustainability Prize Opens Submissions for 2023 Cycle
2022-03-15 19:14 Dexcom G7 Receives CE Mark – Next-Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management
2022-03-15 15:14 Nichi GLOW: Japanese Beta-Glucan, in Children With Autism Spectrum Disorder, Improves Behavior, Sleep, and Gut Microbiome in a Clinical Study
2022-03-14 18:59 Join KOREA PACK & ICPI WEEK 2022 to Be Held June 14 – 17, KINTEX, Korea!
2022-03-14 10:52 Alvotech Resolves U.S. Patent and Trade Secret Disputes with AbbVie, Securing U.S. Rights for Alvotech’s Proposed High-Concentration Biosimilar (AVT02) for Humira®
2022-03-14 10:08 The Result of the Phase 3 Study for Prestige BioPharma’s Herceptin Biosimilar, HD201(Tuznue®), Published in JAMA Oncology
2022-03-14 10:05 EKF Life Sciences and ABEC Partner for US Biomanufacturing Expansion
2022-03-11 19:22 Exscientia and University of Oxford Launch “Xcellomics” Program to Expedite Early-Stage Academic Research and Translate Novel Biology Into Future Drug Discovery
2022-03-11 10:22 ANANDA Scientific and NYU Grossman School of Medicine Announce First Patient Enrolled in the Clinical Trial for Opioid Sparing in Participants with Radiculopathic Pain
2022-03-10 13:55 Exscientia to Highlight Precision Medicine Platform and Pipeline Data at the American Association of Cancer Research Annual Meeting 2022
2022-03-09 19:27 Dr. Andreas Amrein Joins Advanced Clinical to Lead Global Development and Expansion in APAC, Europe and Canada
2022-03-09 10:10 Medical Korea 2022 to Discuss Changes and Future Direction of Global Healthcare Industry
2022-03-08 15:38 Preclinical Data of Prestige Biopharma’s First-in-Class Pancreatic Cancer Treatment, PBP1510, Presented in ESMO TAT 2022
2022-03-08 14:54 Mawi DNA Technologies Nabs CE Certification for Sample Collection Product Portfolio
2022-03-08 14:18 Publication of definitive Interim Result for Vifor Pharma tender offer: CSL Behring AG declares offer successful
2022-03-07 15:30 Jardiance® (empagliflozin) becomes the first and only approved treatment in Europe for adults with symptomatic chronic heart failure regardless of ejection fraction
2022-03-07 09:42 ABEC Continues Proactive Investment in Single-Use Manufacturing Capacity
2022-03-04 16:21 BioNTech Chief Operating Officer Dr. Sierk Poetting to Steer IQM Global Expansion as Chairman; Axel Thierauf Transitions into a New Role as the Chair of IQM Quantum Council.
2022-03-04 13:51 The OPTRACT Method: Efficient Human Donor Cornea Transportation Feat & Futuristic Cell Repository in Zero-gravity for Space-age, Anti-aging Research; Strategy by Japanese Scientists.
2022-03-04 13:49 Allscripts to Sell the Net Assets of Its Hospitals & Large Physician Practices Business Segment to Constellation Software

Business Wire Weibo

Press Releases

Latest Releases